| 產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購(gòu) |
|---|---|---|---|---|---|---|---|
| GC36828-10mg |
|
— |
Oxaprozin D4 - Glpbio |
0 | 需詢價(jià) | C18H11D4NO3 | |
| GC36828-5mg |
|
— |
Oxaprozin D4 - Glpbio |
0 | 需詢價(jià) | C18H11D4NO3 | |
| GC36828-1mg |
|
— |
Oxaprozin D4 - Glpbio |
0 | 需詢價(jià) | C18H11D4NO3 | |
| GC36826-10mg |
|
— |
OVA G4 peptide TFA - Glpbio |
0 | 需詢價(jià) | C45H72F3N9O14 | |
| GC36826-5mg |
|
— |
OVA G4 peptide TFA - Glpbio |
0 | 需詢價(jià) | C45H72F3N9O14 | |
| GC36826-1mg |
|
— |
OVA G4 peptide TFA - Glpbio |
0 | 需詢價(jià) | C45H72F3N9O14 | |
| GC36825-10mg |
|
148274-82-2 |
OVA G4 peptide - Glpbio |
0 | 需詢價(jià) | C43H71N9O12 | |
| GC36825-5mg |
|
148274-82-2 |
OVA G4 peptide - Glpbio |
0 | 需詢價(jià) | C43H71N9O12 | |
| GC36825-1mg |
|
148274-82-2 |
OVA G4 peptide - Glpbio |
0 | 需詢價(jià) | C43H71N9O12 | |
| GC36823-10mg |
|
364071-17-0 |
OT-R antagonist 1 - Glpbio |
0 | 需詢價(jià) | C28H29N3O4 | |
| GC36823-5mg |
|
364071-17-0 |
OT-R antagonist 1 - Glpbio |
0 | 需詢價(jià) | C28H29N3O4 | |
| GC36823-1mg |
|
364071-17-0 |
OT-R antagonist 1 - Glpbio |
0 | 需詢價(jià) | C28H29N3O4 | |
| GC36821-50mg |
|
2070015-22-2 |
OSU-T315 - Glpbio |
0 | 需詢價(jià) | C30H30F3N5O | |
| GC36821-10mg |
|
2070015-22-2 |
OSU-T315 - Glpbio |
0 | 需詢價(jià) | C30H30F3N5O | |
| GC36821-5mg |
|
2070015-22-2 |
OSU-T315 - Glpbio |
0 | 需詢價(jià) | C30H30F3N5O | |
| GC36821-2mg |
|
2070015-22-2 |
OSU-T315 - Glpbio |
0 | 需詢價(jià) | C30H30F3N5O | |
| GC36821-10mM (in 1mL DMSO) |
|
2070015-22-2 |
OSU-T315 - Glpbio |
0 | 需詢價(jià) | C30H30F3N5O | |
| GC36820-100mg |
|
841205-47-8 |
Ostarine - Glpbio |
0 | 需詢價(jià) | C19H14F3N3O3 | |
| GC36820-50mg |
|
841205-47-8 |
Ostarine - Glpbio |
0 | 需詢價(jià) | C19H14F3N3O3 | |
| GC36820-10mg |
|
841205-47-8 |
Ostarine - Glpbio |
0 | 需詢價(jià) | C19H14F3N3O3 | |
小泰
|
010-60710855
|